Literature DB >> 21794064

Prognostic implications of lymph node involvement in bladder cancer: are we understaging using current methods?

Kara L Watts1, Benjamin T Ristau, Harold T Yamase, John A Taylor.   

Abstract

To review the current and newer, alternative methods for evaluating lymph nodes for tumor involvement in bladder cancer as relapse rates for organ-confined disease remain high despite improvements in surgical technique, suggesting the possibility of understaging. To propose a research agenda based on these findings. A PubMed literature search was performed to identify studies examining the prognostic implications of and outcomes associated with lymph node involvement in bladder cancer as well as those that utilized newer methodologies to identify the possibility for metastatic disease. Lymph node involvement remains one of the strongest predictors of clinical outcome in bladder cancer. Histologic and molecular techniques for identification of lymph node metastasis provide a sensitivity and specificity equal to if not higher than standard pathologic evaluation. Further research into this field would help to elucidate the potential utility of these techniques with regard to proper staging and potential relevance to clinical outcomes.
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21794064     DOI: 10.1111/j.1464-410X.2011.10330.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  2 in total

1.  Increased expression of L-selectin (CD62L) in high-grade urothelial carcinoma: A potential marker for metastatic disease.

Authors:  Dharamainder Choudhary; Poornima Hegde; Olga Voznesensky; Shilpa Choudhary; Stavros Kopsiaftis; Kevin P Claffey; Carol C Pilbeam; John A Taylor
Journal:  Urol Oncol       Date:  2015-01-22       Impact factor: 3.498

Review 2.  The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer.

Authors:  Christopher M Russell; Amir H Lebastchi; Tudor Borza; Daniel E Spratt; Todd M Morgan
Journal:  Bladder Cancer       Date:  2016-10-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.